4//SEC Filing
Shmagin Martin E 4
Accession 0001013762-09-000395
CIK 0000932352other
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 1:24 PM ET
Size
6.4 KB
Accession
0001013762-09-000395
Insider Transaction Report
Form 4
Urigen Pharmaceuticals, Inc.UGRP.OB
Shmagin Martin E
DirectorChief Financial Officer
Transactions
- Purchase
Common Stock, $.001 Par Value
2009-03-06$0.08/sh+1,000$80→ 3,131,073 total - Purchase
Common Stock, $.001 Par Value
2009-03-05$0.08/sh+4,000$320→ 3,130,073 total
Documents
Issuer
Urigen Pharmaceuticals, Inc.
CIK 0000932352
Entity typeother
Related Parties
1- filerCIK 0001407236
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 1:24 PM ET
- Size
- 6.4 KB